National and Kapodistrian University of Athens
Διερεύνηση μεταλλάξεων του μιτοχονδριακού DNA σε πρωτοπαθή μυελοδυσπλαστικά σύνδρομα
Abstract
dc:descriptionMitochondria play an important role in both apoptosis and haem synthesis. Given the appreciation of their significant contribution to maintain cellular homeostasis it is not surprising that mitochondrial mutations are associated with a variety of both congenital diseases (Pearson’s syndrome) as well as acquired ones such as various cancers.Due to their significant contribution to the regulation of haem synthesis and apoptosis, we were interested in investigating the role of mitochondrial DNA mutations in Myelodysplastic syndromes in which iron laden mitochondria are associated with variable cytopenias and apoptosis of hematopoietic cells and correlate the findings with clinical characteristics as well as to the level of apoptosis.Our analysis included 55 cases of de novo MDS (38 male, 17 female) with a median age 71.5 (43-87). In 29/55 cases apoptosis was calculated by flow cytometry on freshly isolated total bone marrow mononuclear cells as well as on CD34+ cells. Early apoptotic cells were classified as Annexin V + cells and late apoptotic as Annexin V+/PI + cells.Of the 55 cases, 47 were analyzed for mitochondrial cytochrome c-oxidase I and II gene mutations using PCR amplification and direct sequencing analysis. Bone marrow cells from 13 patients with lymphoma without bone marrow involvement were used as controls.RESULTS No statistically significant difference was found between early and late apoptosis of total cells and CD34+ cells in patients with MDS and normal controls. No statistically significant association was detected between all these parameters and FAB, WHO and IPSS classifications. However, a significant higher median value of CD34+ late apoptotic cells was found in cases with ≥ 5% bone marrow blast percentage. Moreover, the median percentage value of late apoptosis was significantly higher in total bone marrow mononuclear cells compared to CD34+ cells. The analysis of Cytochrome C I and II gene mutations detected 3/47 cases with mutations: One case with RAEB-II and Intermediate-II IPSS was characterized by a silent T to C change at nt position 7374 of cytochrome C-oxidase I gene, a second case with RARS and intermediate-I IPSS had a C to T change at nt 7868 of cytochrome C-oxidase II gene resulting in Leu to Phe substitution and a case with RAEB-I and Intermediate-I IPSS had a silent C to T change at nt 7875 of the same gene.CONCLUSIONS In our series, cases with blast percentage ≥ 5% were characterized by significantly higher numbers of late apoptotic CD34+ cells. Late apoptosis is significantly higher in total mature bone marrow cells compared to primitive CD34+ cells. Cytochrome C oxidase I and II gene mutations were not a frequent phenomenon, detected in 6.4 % of cases. It is interesting to note that 1/3 cases with RARS was characterized by a cytochrome C-oxidase II gene mutation resulting in aminoacid substitution, stressing the importance of these mutations in this MDS subtype.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Girkas, Konstantinos
- Γκίρκας, Κωνσταντίνος
Subjects
dc:subject × 20- Μυελοδυσπλαστικά σύνδρομα
- Απόπτωση
- Κυτόχρωμα
- Μεταλλάξεις
- Οξείδαση κυτοχρωμική
- Μιτοχόνδρια
- Αννεξίνη
- Myelodysplastic syndromes
- Apoptosis
- Cytochrome
- Cytochrome oxidase
- Mutations
- Mitochondria
- Annexin
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Clinical Medicine
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40558